Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Koziorowska A et al. | 2016 | intact cell/cell culture, pig pinealocytes | magnetic field, 50/60 Hz | 2.5 mT |
| Koziorowska A et al. | 2017 | intact cell/cell culture, human neonatal fibroblast BJ | 50/60 Hz, magnetic field, low frequency, signals/pulses | 2.5 mT |
| Koziorowska A et al. | 2018 | - | 50/60 Hz, low frequency, magnetic field | - |
| Koziorowska A et al. | 2017 | intact cell/cell culture, pig anterior pituitary gland cells | magnetic field, 50/60 Hz, low frequency | 2–6 mT |
| Koziorowska A et al. | 2017 | intact cell/cell culture, 143B (human osteosarcoma cell line), BJ (human fibroblast cell line) | 50/60 Hz, magnetic field | 2–6 mT |
| Kula B et al. | 1996 | intact cell/cell culture, fibroblasts | magnetic field, static magnetic field, low frequency, 50/60 Hz | 20–490 mT |
| Kurian MV et al. | 2012 | intact cell/cell culture, H9c2 cells (myoblast from embryonal rat myocard) | magnetic field, 50/60 Hz, co-exposure | 1–240 µT |
| Kwee S et al. | 1995 | intact cell/cell culture, AMA cells (human epithelial amnion cells) and K14 cells (human skin fibroblasts) | magnetic field, low frequency, 50/60 Hz | 25–180 µT |
| Lazzarini R et al. | 2023 | intact cell/cell culture, MDA-MB-231 cells (breast cancer cell line) and MDA-MB-231 (human breast cell line) | magnetic field, 50/60 Hz | - |
| Lim HM et al. | 2021 | intact cell/cell culture, human dental pulp stem cells | magnetic field, signals/pulses, low frequency, 50/60 Hz | 10 mT |
| Loberg LI et al. | 2000 | intact cell/cell culture, MCF-7, ZR-75-1, T-47D, and MDA-MB-231 (breast cancer cell line) and normal human breast epithalial cells | magnetic field, 50/60 Hz | 1 mT |
| Luukkonen J et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
| Mansoury F et al. | 2021 | intact cell/cell culture | magnetic field, low frequency, 50/60 Hz | 0.25–2 mT |
| Mansoury F et al. | 2022 | intact cell/cell culture, human gastric adenocarcinoma (AGS) and human normal fibroblast (Hu02) cell lines | magnetic field, 50/60 Hz | - |
| Markkanen A et al. | 2001 | yeast (<i>Saccharomyces cerevisiae</i>/SEy2101a) | magnetic field, 50/60 Hz, co-exposure | 120 µT |
| Masoudi-Khoram N et al. | 2022 | intact cell/cell culture, MCF-7 and MDA-MB-231 (human breast cancer cell lines) | magnetic field, low frequency, 50/60 Hz | - |
| Master AM et al. | 2016 | - | magnetic field, 50/60 Hz, signals/pulses, co-exposure | - |
| Mercado-Sáenz S et al. | 2019 | - | magnetic field, 50/60 Hz, signals/pulses | - |
| Miyakoshi J et al. | 1994 | intact cell/cell culture, human leukemia cell lines (HL60RG, CCRF-CEM9), GM0637 cells (normal human fibroblast cell line), TAT2SF cells (human Louis-Bar syndrome fibroblast cell line) | magnetic field, 50/60 Hz, also other exposures without EMF | 400 mT |
| Miyakoshi J et al. | 1997 | intact cell/cell culture, MeWo cells (malignant melanoma cells) | magnetic field, 50/60 Hz, also other exposures without EMF | 400–500 mT |
| Miyakoshi J et al. | 2000 | intact cell/cell culture, MO54 cells (derived from a human malignant glioma) | magnetic field, 50/60 Hz, co-exposure | 5–400 mT |
| Morabito C et al. | 2017 | - | magnetic field, 50/60 Hz | - |
| Mousavi Maleki NS et al. | 2022 | intact cell/cell culture, human adenocarcinoma gastric cancer cell line (AGS) | magnetic field, 50/60 Hz | - |
| Moya-Gómez A et al. | 2023 | intact cell/cell culture, BV2 cells (immortalized murine microglial cell line), SHSY5Y cells, (immortalized human neuroblastoma cell line), primary mouse microglia and neurons, animal, mongolian gerbils <i>(Meriones unguiculatus)</i> (stroke model) | 50/60 Hz, magnetic field | - |
| Nakayama M et al. | 2016 | intact cell/cell culture, macrophages (RAW 246) | magnetic field, 50/60 Hz, co-exposure | 500 µT |
| Nawrotek P et al. | 2014 | bacterium, <i>Escherichia coli</i>/O157:H7 and E68II/0141 and <i>Staphylococcus aureus</i>/FRI 913, ATCC 25923 and ATCC 43300 | magnetic field, 50/60 Hz | 30 mT |
| Nguyen H et al. | 2023 | intact cell/cell culture, TK6 cells (lymphoblastoma cells) | magnetic field, 50/60 Hz | - |
| Nieminen V et al. | 2022 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | static magnetic field, magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
| Novak J et al. | 2007 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>) | magnetic field, 50/60 Hz | 5.2–10 mT |
| Nurković J et al. | 2017 | - | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
| Panjali Z et al. | 2022 | intact cell/cell culture, A549 (human lung cancer cell line) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Pieroni L et al. | 1998 | intact cell/cell culture, virus/bacteriophages, murine B lymphocytes and T lymphocytes infected with a murine retrovirus (Mo-MLV) | magnetic field, 50/60 Hz | 1 mT |
| Rahimi S et al. | 2023 | intact cell/cell culture, dental pulp multipotent stromal stem cells | magnetic field, signals/pulses, 50/60 Hz | - |
| Rajendra P et al. | 2012 | intact cell/cell culture, sheep primary lymphocytes | 50/60 Hz, magnetic field | 5–100 µT |
| Ramazi S et al. | 2023 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and HFF cells (human foreskin fibroblast cells) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Ramstad S et al. | 2000 | bacterium, <i>Propionibacterium acnes</i> | electric field, magnetic field, 50/60 Hz | 200 µT |
| Razavi S et al. | 2014 | intact cell/cell culture, human adipose derived stem cells | magnetic field, 50/60 Hz | 0.5–1 mT |
| Reale M et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Reipert BM et al. | 1997 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2 µT–2 mT |
| Ruiz-Gomez MJ et al. | 2010 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/WS8105-1C (genotype <i>MATalpha, ade2, arg4-17, trp1-289, ura3-52</i>: a marker which stains the colonies red) | magnetic field, static magnetic field, 50/60 Hz, DC | 0.35–2.45 mT |
| Saikia J et al. | 2019 | isolated bio./chem. substance, beta-amyloid protein | electric field, magnetic field, 50/60 Hz, static electric field | - |
| Sakurai T et al. | 2008 | intact cell/cell culture, HIT-T15 cells (hamster-derived insulin-secreting cell line) | magnetic field, low frequency, 50/60 Hz | 5 mT |
| Salek F et al. | 2021 | intact cell/cell culture | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 2.5 mT |
| Samiei M et al. | 2020 | intact cell/cell culture, human dental pulp stem cells | magnetic field, 50/60 Hz | 0.5–1 mT |
| Sanie-Jahromi F et al. | 2016 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 0.25–0.5 mT |
| Sanie-Jahromi F et al. | 2017 | - | magnetic field, 50/60 Hz, co-exposure | - |
| Schimmelpfeng J | 1997 | intact cell/cell culture, HL-60 (human promyelocytic leukemia cells) | magnetic field, 50/60 Hz, co-exposure | 2 mT |
| Schimmelpfeng J et al. | 1997 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) and HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
| Sendera A et al. | 2024 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, low frequency | - |
| Shahbazi-Gahrouei D et al. | 2014 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | 50/60 Hz, magnetic field | 0.5–1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
